Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis

References

• Latorre R, Vaquero J, Rincon D, Puerto M, Ponce MD, Sarnago F, Matamoros JA, Ramon E, Elizaga J, Banares R et al. Determinants of platelet count are different in patients with compensated and decompensated cirrhosis. Liver Int 2016;36(2):232–239.
   PubMed Web of Science ®Google Scholar
• Lisman T, Kwaan HC. Hemostatic dysfunction in liver diseases. Semin Thromb Hemost 2015;41(5):445–446.
   PubMed Web of Science ®Google Scholar
• Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005;41(3):553–558.
   PubMed Web of Science ®Google Scholar
• Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: Evidence and clinical consequences. Blood 2010;116(6):878–885.
   PubMed Web of Science ®Google Scholar
• Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55(6):1415–1427.
   PubMed Web of Science ®Google Scholar
• Vinholt PJ, Frederiksen H, Hvas AM, Sprogøe U, Nielsen C. Measurement of platelet aggregation, independent of patient platelet count: A flow-cytometric approach. J Thromb Haemost 2017;15(6):1191–1202.
   PubMed Web of Science ®Google Scholar
• Rubak P, Nissen PH, Kristensen SD, Hvas AM. Investigation of platelet function and platelet disorders using flow cytometry. Platelets 2016;27(4):295–300.
   PubMedGoogle Scholar
• Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D, VWF ISj, Perinatal/Pediatric Hemostasis Subcommittees Working G. Isth/ssc bleeding assessment tool: A standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010;8(9):2063–2065.
   Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60(8):646–649.
   PubMed Web of Science ®Google Scholar
• Vinholt PJ, Nybo M, Brødsgaard C, Hvas AM. Light transmission aggregometry using pre-coated microtiter plates and a victor ×5 plate reader. (under review).
   Google Scholar
• Lordkipanidze M, Lowe GC, Kirkby NS, Chan MV, Lundberg MH, Morgan NV, Bem D, Nisar SP, Leo VC, Jones ML et al. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: Use of 96-well optimul assay. Blood 2014;123(8):e11–22.
   PubMed Web of Science ®Google Scholar
• Michelson AD. Flow cytometry: A clinical test of platelet function. Blood 1996;87(12):4925–4936.
   PubMed Web of Science ®Google Scholar
• Jackson SP. The growing complexity of platelet aggregation. Blood 2007;109(12):5087–5095.
   PubMed Web of Science ®Google Scholar
• Pihusch R, Rank A, Gohring P, Pihusch M, Hiller E, Beuers U. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 2002;37(5):548–555.
   PubMed Web of Science ®Google Scholar
• Ogasawara F, Fusegawa H, Haruki Y, Shiraishi K, Watanabe N, Matsuzaki S. Platelet activation in patients with alcoholic liver disease. Tokai J Exp Clin Med 2005;30(1):41–48.
   PubMedGoogle Scholar
• Ingeberg S, Jacobsen P, Fischer E, Bentsen KD. Platelet aggregation and release of atp in patients with hepatic cirrhosis. Scand J Gastroenterol 1985;20(3):285–288.
   PubMed Web of Science ®Google Scholar
• Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R et al. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol 2006;12(10):1607–1612.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP et al. Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the platelet physiology subcommittee of ssc/isth. J Thromb Haemost 2013;11(6):1183–1193.
   Web of Science ®Google Scholar
• Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, Machin S, British Committee for Standards in H. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011;155(1):30–44.
   Google Scholar
• Vinholt PJ, Hvas AM, Nybo M. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients. Eur J Haematol 2014;92(5):367–376.
   PubMed Web of Science ®Google Scholar
• Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK, Platelet Physiology Subcommittee of the S, Standardization Committee of the International Society on T, Haemostasis. Platelet function analyzer (pfa)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006;4(2):312–319.
   Google Scholar
• Gresele P, Subcommittee on Platelet Physiology of the International Society on T, Hemostasis. Diagnosis of inherited platelet function disorders: Guidance from the ssc of the isth. J Thromb Haemost 2015;13(2):314–322.
   Google Scholar
• Lisman T. Assessing in vivo platelet activation in patients with liver diseases. J Thromb Thrombolysis 2017; 43(1):52–53.
   PubMed Web of Science ®Google Scholar
• Beer JH, Clerici N, Baillod P, von Felten A, Schlappritzi E, Buchi L. Quantitative and qualitative analysis of platelet gpib and von willebrand factor in liver cirrhosis. Thromb Haemost 1995;73(4):601–609.
   PubMed Web of Science ®Google Scholar
• Ramstrom S, Sodergren AL, Tynngard N, Lindahl TL. Platelet function determined by flow cytometry: New perspectives? Semin Thromb Hemost 2016;42(3):268–281.
   PubMed Web of Science ®Google Scholar
• Barrison IG, Viola L, Murray-Lyon IM. Platelet prostaglandin production in alcoholic liver disease. Prostaglandins Leukot Med 1983;10(3):331–344.
   PubMedGoogle Scholar
• Salem RO, Laposata M. Effects of alcohol on hemostasis. Am J Clin Pathol 2005;123 Suppl:S96–105.
   PubMedGoogle Scholar
• Thomas DP. Abnormalities of platelet aggregation in patients with alcoholic cirrhosis. Ann N Y Acad Sci 1972;201:243–250.
   PubMed Web of Science ®Google Scholar
• Ballard HS, Marcus AJ. Platelet aggregation in portal cirrhosis. Arch Intern Med 1976;136(3):316–319.
   PubMedGoogle Scholar
• Potze W, Siddiqui MS, Boyett SL, Adelmeijer J, Daita K, Sanyal AJ, Lisman T. Preserved hemostatic status in patients with non-alcoholic fatty liver disease. J Hepatol 2016;65(5):980–987.
   PubMed Web of Science ®Google Scholar
• Frelinger AL, 3rd, Grace RF, Gerrits AJ, Berny-Lang MA, Brown T, Carmichael SL, Neufeld EJ, Michelson AD. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood 2015;126(7):873–879.
   PubMed Web of Science ®Google Scholar
• Joergensen MK, Bathum L. Reference intervals for mean platelet volume and immature platelet fraction determined on a sysmex xe5000 hematology analyzer. Scand JClin Lab Invest 2016;76(2):172–176.
   PubMed Web of Science ®Google Scholar
• Ouwendijk RJ, Zijlstra FJ, Wilson JH, Bonta IL, Vincent JE. Raised plasma thromboxane b2 levels in alcoholic liver disease. Prostaglandins Leukot Med 1983;10(2):115–122.
   PubMedGoogle Scholar
• Sanchez-Roig MJ, Rivera J, Moraleda JM, Garcia VV. Quantitative defect of glycoprotein ib in severe cirrhotic patients. Am J Hematol 1994;45(1):10–15.
   PubMed Web of Science ®Google Scholar
• Panasiuk A, Zak J, Panasiuk B, Prokopowicz D. Increase in expression of monocytic tissue factor (cd142) with monocytes and blood platelet activation in liver cirrhosis. Blood Coagul Fibrinolysis 2007;18(8):739–744.
   PubMed Web of Science ®Google Scholar